Proteologix’s antibody PX128 is ready to enter early-stage development for moderate to severe atopic dermatitis, commonly referred to as eczema, and moderate to severe asthma.
Trending
- Gov Otti inaugurates modern bus terminal in Umuahia
- African leaders call for more investment in energy, infrastructure
- Foundation urges govt to free abducted children
- FCT motorists accuse fuel stations of pump tampering
- Gov Bago pays Sallah visits to Babangida, Abdulsalami
- ADC aspirant petitions party over alleged irregularities in Kaduna primaries
- Gov Eno inaugurates projects in Oron
- Masterminds foundation holds emotional intelligence programme for students
